Cargando…

Characteristics and Prognosis of Hepatocellular Carcinoma in Multi-Transfused Patients with β-Thalassemia. Experience of a Single Tertiary Center

BACKGROUND/AIM: The incidence of hepatocellular carcinoma (HCC) in patients with transfusion dependent thalassemia (TDT) has been increasing, where viral hepatitis and iron overload are the two established HCC risk factors. The aim of this study was to investigate the etiological factors of HCC deve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Papadopoulos, Nikolaos, Kountouras, Dimitrios, Malagari, Katerina, Tampaki, Maria, Theochari, Maria, Koskinas, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Università Cattolica del Sacro Cuore 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059739/ https://www.ncbi.nlm.nih.gov/pubmed/32180908 http://dx.doi.org/10.4084/MJHID.2020.013

Ejemplares similares

Association of TIM-3 with BCLC Stage, Serum PD-L1 Detection, and Response to Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma
por: Tampaki, Maria, et al.
Publicado: (2020)

Impact of direct-acting antiviral agents on the development of hepatocellular carcinoma: evidence and pathophysiological issues
por: Tampaki, Maria, et al.
Publicado: (2018)

Clinical Characteristics, Spontaneous Clearance and Treatment Outcome of Acute Hepatitis C: A Single Tertiary Center Experience
por: Deutsch, Melanie, et al.
Publicado: (2013)

The changing epidemiology of hepatocellular carcinoma in Greece
por: Markakis, George E., et al.
Publicado: (2022)

P1508: LUSPATERCEPT REDUCES THE BURDEN OF RED BLOOD CELL TRANSFUSION IN PATIENTS WITH BETA -THALASSEMIA AND COMORBIDITIES: THE EXPERIENCE OF A SINGLE THALASSEMIA AND SICKLE CELL UNIT IN A UNIVERSITY HOSPITAL
por: Delicou, S., et al.
Publicado: (2022)

Ocular abnormalities in multi-transfused beta-thalassemia patients
por: Jafari, Reza, et al.
Publicado: (2015)

Beta-Thalassemia Major and Female Fertility: The Role of Iron and Iron-Induced Oxidative Stress
por: Roussou, Paraskevi, et al.
Publicado: (2013)

Transient Elastography (TE) is a Useful Tool for Assessing the Response of Liver Iron Chelation in Sickle Cell Disease Patients
por: Delicou, Sophia, et al.
Publicado: (2018)

Chemoembolization of Hepatocellular Carcinoma with Hepasphere 30–60 μm. Safety and Efficacy Study
por: Malagari, Katerina, et al.
Publicado: (2013)

2021 Thalassaemia International Federation Guidelines for the Management of Transfusion-dependent Thalassemia
por: Farmakis, Dimitrios, et al.
Publicado: (2022)

Cellular, Molecular and Proteomic Characteristics of Early Hepatocellular Carcinoma
por: Armakolas, Athanasios, et al.
Publicado: (2022)

Link between Genotype and Multi-Organ Iron and Complications in Children with Transfusion-Dependent Thalassemia
por: Meloni, Antonella, et al.
Publicado: (2022)

Detection of endocrine disorders in young children with multi-transfused thalassemia major
por: Mahmoud, Ramadan A., et al.
Publicado: (2021)

Luspatercept for transfusion-dependent β-thalassemia: time to get real
por: Musallam, Khaled M., et al.
Publicado: (2023)

β-Thalassemia Mutations among Transfusion-Dependent Thalassemia Major Patients in Northern Iraq
por: Al-Allawi, Nasir A. S., et al.
Publicado: (2010)

Pulmonary Functions in Transfusion-Dependent Thalassemia
por: Chandra, Jagdish, et al.
Publicado: (2022)

Blood transfusion among thalassemia patients: A single Egyptian center experience
por: Ragab, Lamis A., et al.
Publicado: (2013)

Characterization of pediatric transfusion‐dependent thalassemia patients in a large academic center
por: Zarrabian, Dorsa, et al.
Publicado: (2023)

Hydroxyurea Treatment in Transfusion-Dependent β-Thalassemia Patients
por: Bordbar, Mohammad Reza, et al.
Publicado: (2014)

Seroprevalence of hepatitis C virus markers in multi-transfused children with beta-thalassemia
por: Madhusudhan, Kiran, et al.
Publicado: (2012)

Blood group genotyping in alloimmunized multi‐transfused thalassemia patients from Iran
por: Sarihi, Reyhaneh, et al.
Publicado: (2021)

S270: TRANSFUSION INDEPENDENCE AFTER EXAGAMGLOGENE AUTOTEMCEL IN PATIENTS WITH TRANSFUSION-DEPENDENT ΒETA-THALASSEMIA
por: Locatelli, Franco, et al.
Publicado: (2023)

Molecular Analysis of Non-Transfusion Dependent Thalassemia Associated with Hemoglobin E-β-Thalassemia Disease without α-Thalassemia
por: Phanrahan, Paramee, et al.
Publicado: (2019)

Non-Transfusion-Dependent Thalassemia: An Update on Complications and Management
por: Sleiman, Joseph, et al.
Publicado: (2018)

How I treat non-transfusion-dependent β-thalassemia
por: Saliba, Antoine N., et al.
Publicado: (2023)

Alloimmunization among transfusion-dependent thalassemia patients
por: Sadeghian, Mohammad Hadi, et al.
Publicado: (2009)

Glomerular and Tubular Functions in Transfusion-Dependent Thalassemia
por: Sookaromdee, Pathum, et al.
Publicado: (2018)

Quality of life in transfusion-dependent thalassemia patients
por: Alzahrani, Rizqallah A., et al.
Publicado: (2017)

Hypoparathyroidism in a Case of Transfusion Dependent Thalassemia
por: Majumder, Anirban, et al.
Publicado: (2020)

Transfusion Complications in Thalassemia: Patient Knowledge and Perspectives
por: Patterson, Sashoy, et al.
Publicado: (2022)

The transfusion management of beta thalassemia in the United States
por: Lal, Ashutosh, et al.
Publicado: (2021)

Alloantibody among Thalassemia patients receiving multiple blood transfusions at a tertiary care hospital in India
por: Thakur, Sanjay Kumar, et al.
Publicado: (2023)

Iron Overload and Chelation Therapy in Non-Transfusion Dependent Thalassemia
por: Bou-Fakhredin, Rayan, et al.
Publicado: (2017)

Marital status and paternity in patients with Transfusion-Dependent Thalassemia (TDT) and Non Transfusion-Dependent Thalassemia (NTDT): an ICET - A survey in different countries
por: De Sanctis, Vincenzo, et al.
Publicado: (2019)

Experience of hepatitis C virus seroprevalence and its genomic diversity among transfusion-dependent thalassemia patients in a transfusion center
por: Bhattacharyya, Kallol Kumar, et al.
Publicado: (2018)

Contrast Sensitivity in Patients with Beta-Thalassemia Major and Sickle Cell Disease Under Regular Transfusions and Treatment with Desferrioxamine
por: Gorezis, Spyridon, et al.
Publicado: (2010)

Profile of deferasirox for the treatment of patients with non-transfusion-dependent thalassemia syndromes
por: Ricchi, Paolo, et al.
Publicado: (2015)

Mutational analysis of thalassemia in transfusion-dependent beta-thalassemia patients from central India
por: Shrivastava, Manisha, et al.
Publicado: (2019)

Premature Atherosclerosis in Children With Transfusion-Dependent Thalassemia: A Twin-Center Cross-Sectional Study
por: Kumaravel, K. S., et al.
Publicado: (2022)

Beta Thalassemia: New Therapeutic Options Beyond Transfusion and Iron Chelation
por: Motta, Irene, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1j09omodughsdoi5jod72raqmf